The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post–Pulmonary Embolism Syndrome
Journal of Vascular and Interventional Radiology · 2025
DOI: 10.1016/j.jvir.2025.02.024 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular and Interventional Radiology, 2025. Verfasst von Lasya Daggumati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City School of Medicine, University of Missouri, Kansas City, Missouri. Hauptthemen laut MEDLINE: Venous Thrombosis, Pulmonary Embolism, Thrombolytic Therapy, Fibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart Lung and Blood Institute.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
In the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) trial, 691 patients were randomly assigned to receive or not receive pharmacomechanical catheter-directed thrombolysis (PCDT) to treat acute proximal deep vein thrombosis (DVT). Serious adverse events and suspected pulmonary embolism (PE) (collectively, "late symptom events" [LSEs]) were reported. An independent physician, blinded to treatment allocation, categorized LSEs occurring 1-24 months after randomization by whether they could relate to post-PE syndrome. PE-related LSEs were frequent (66.7%) in patients who presented with diagnosed or suspected PE and infrequent (2.0%) in others; however, PCDT did not influence their occurrence (PCDT, 11.0% vs No-PCDT, 11.0; P = 1.000). However, in the iliofemoral DVT subgroup, patients in the PCDT arm had fewer PE-related LSEs per patient (PCDT, 0.14 vs No-PCDT, 0.24; P = .036) and fewer PE-related breathing/lung LSEs per patient (PCDT, 0.08 vs No-PCDT, 0.16; P = .023). PCDT was associated with a lower incidence of PE-related LSEs in patients with iliofemoral DVT who presented with PE symptoms at baseline. Evaluation for post-PE syndrome after DVT thrombolysis can be focused on this subset of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kansas City School of Medicine, University of Missouri, Kansas City, Missouri.
- Health Canada, Ottawa, Ontario, Canada.
- OhioHealth Heart and Vascular, Columbus, Ohio.
- Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
- Interventional Radiology Section, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: vedanthams@wustl.edu.
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- National Heart Lung and Blood Institute
Zitieren
APA
Daggumati, L., Gu, C. S., Kolluri, R., Kavali, P., & Vedantham, S. (2025). The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post–Pulmonary Embolism Syndrome. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2025.02.024
Vancouver
Daggumati L, Gu CS, Kolluri R, Kavali P, Vedantham S. The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post–Pulmonary Embolism Syndrome. Journal of Vascular and Interventional Radiology. 2025. doi:10.1016/j.jvir.2025.02.024
BibTeX
@article{Daggumati2025,
author = {Daggumati, Lasya and Gu, Chu-Shu and Kolluri, Raghu and Kavali, Pavan and Vedantham, Suresh},
title = {The Effect of Thrombolysis of Deep Vein Thrombosis on Late Symptoms of Post–Pulmonary Embolism Syndrome},
journal = {Journal of Vascular and Interventional Radiology},
year = {2025},
doi = {10.1016/j.jvir.2025.02.024}
}
EUVIMED